Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Bausch & Lomb announced a new partnership and introduced four new products to the U.S. market for ...

Please provide your email address to receive an email when new articles are posted on . The Eyetelligence platform features new surgical planning software. The software has a surgeon-focused app and a ...

Bausch + Lomb, a portfolio company of Welsh Carson, has named three executives to management positions in its surgical business. Brad Paddock was hired as vice president of sales. Anthony Sine was ...

VAUGHAN, Ontario & HEIDELBERG, Germany — Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, and Heidelberg Engineering, today announced the ...

(RTTNews) - Bausch + Lomb Corporation (BLCO) announced on Monday that the FDA has approved the TENEO Excimer Laser Platform (Technolas Teneo 317 Model 2) for LASIK surgery to correct myopia and myopic ...

Bausch & Lomb Inc. said Thursday that it appointed Allergan Inc. executive Robert Grant as president and chief executive of its Aliso Viejo-based eye surgery business. Grant, a corporate vice ...

LOTEMAX SM Is Formulated with SubMicron Technology for Efficient Penetration To Key Ocular Tissues 1 BRIDGEWATER, N.J., Feb. 25, 2019 /CNW/ -- Bausch + Lomb, a leading global eye health company and ...

BRIDGEWATER, N.J., Dec. 17, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TXS: BHC), announced today that it has initiated a clinical ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...

Bausch + Lomb’s third quarter saw a positive market response, as the company posted growth across all major segments and met ...

Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings this Wednesday before the bell. Here’s what to look for.

Canadian drugmaker Bausch Health Companies Inc (BHC.TO) is exploring a potential sale of its eye-care business, Bloomberg News reported on Wednesday, citing people with knowledge of the matter.